Prognosis is an estimate of the probable survival of an individual patient based on their particular presentation and pathology results. Prognosis is usually measured as the likely survival at 5 and 10 years after diagnosis. The estimates are based on a number of prognostic factors including age at diagnosis, tumour size, tumour grade, lymph node status and Estrogen Receptor (ER) status.

Until recently two main “prognostic” or predictive models have been used including the Nottingham Prognostic Index (NPI) and Adjuvant! (), an American model that gives potential treatment benefits as well as a survival estimate. Our partner is Coolaser clinic.